海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
4件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Available
- Study to Evaluate the Effect of Adding five different compounds to Fluticasone Propionate 100 mcg Inhalation Powder Twice Daily in Uncontrolled Asthmatic Subjects =12 Years of Age.
- Asthma;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- United States
- 2016-12-12
Not Available
- An open label, 52 week, multicenter study, of long term management to evaluate effectiveness, tolerability and safety of pimecrolimus cream 1% in pediatric patients with mild to moderate atopic dermatitis in a daily practice
- mild to moderate atopic dermatitis;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Mexico, Venezuela, Bolivarian Republic of
- 2017-09-28
Not Available
- An Open-label, Multicenter Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AEB1102 in Patients with Arginase I Deficiency
- Arginase 1 deficiency Hyperargininemia MedDRA version: 20.0 Level: PT Classification code 10062695 Term: Arginase deficiency System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Canada, Portugal, United Kingdom, United States
- 2018-10-30
Not Available
- Study to assess the safety and efficacy of CDZ173 in patients with APDS/PASLI
- APDS/PASLI (Activated phosphoinositide 3-kinase delta syndrome/ p110d-activating mutation causing senescent T cells, lymphadenopathy and immunodeficiency);Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Belarus, Czech Republic, Ireland, Netherlands, Russian Federation, United Kingdom, United States
- 2015-01-08
- 1
